Navigation Links
More freedom to take risks: DFG funds the first Reinhart Koselleck Projects
Date:12/18/2008

e DFG's Joint Committee, and the DFG has been accepting funding proposals since June 2008.

The first Reinhart Koselleck Projects in brief:

Prof. Dr. Klaus Fiedler (57), social psychology, professor at the Institute of Psychology at the University of Heidelberg

Klaus Fiedler aims to take a cognitive-ecological approach to developing decision making research that includes the ecological limits of rational decision making. With this alternative to traditional approaches to explaining decision making he hopes to find answers to the burning questions of the modern information age. To do so, Fiedler hopes to establish a high-calibre network of leading researchers and stimulate intense debate between younger researchers by means of a special funding programme focussing on the field.

Prof. Dr. Reiner Kirchheim (65), materials science, professor at the Institute of Material Physics at the University of Gttingen

By taking an experimental and theoretical approach, Reiner Kirchheim aims to demonstrate that the well-known effect of surface-active substances can be generalised to apply to defects in solids. This may make it possible to stabilise certain atoms and molecules in materials with defects and to develop novel material properties, for example nanoporous metals as an innovative form of hydrogen storage, or nanocrystalline steel. In addition to this, Kirchheim also wants to find out whether this approach may make it possible to reduce the energy of formation of defects to zero a problem that is also of interest in many other disciplines.

Prof. Dr. Dominik Marx (45), theoretical chemistry, professor at the Faculty of Chemistry and Biochemistry at the Ruhr University of Bochum

Dominik Marx is interested in the theoretical study of chemical reactions that are brought about by mechanical effects on chemicals, and in particular by intramolecular electron pair bonding. These processes are funda
'/>"/>

Contact: Dr. Eva-Maria Streier
em.streier@dfg.de
49-228-885-2250
Deutsche Forschungsgemeinschaft
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related biology news :

1. Cost of hatchling turtles dash for freedom
2. Keck Foundation funds study of biological interactions with nanomaterials
3. Genes and environment grant funds close look at nature-nurture overlap in common diseases
4. NHGRI funds new Centers for Excellence in Ethical, Legal and Social Implications Research
5. USDA Cooperative Agreement funds mosquito project at Rutgers
6. BP funds scholarship for University of Houston to help fill industry ranks
7. OCAST funds OSU projects with commercial viability
8. BP funds energy scholarships for K20 scholars
9. National Science Foundation funds research addressing enduring questions of life
10. W.M. Keck Foundation grant funds reproductive science research
11. Michael J. Fox Foundation Funds $1.1 Million for Cutting-edge Approaches to Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
(Date:12/3/2009)Contents of this message: , , Preliminary Press Conference Topics, Last Call! Press Field Trip to California Academy of Sciences museum, Attention PIOs: Sending Press Releases to Fall meeting, N
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Sakayu Shimizu of Kyoto University recipient of 2009 Enzyme Engineering Award 9960 1Sakayu Shimizu of Kyoto University recipient of 2009 Enzyme Engineering Award 9960 2Regulatory role of key molecule discovered at Hebrew U 9958 1MedTrust Online Surpasses 5 000 Registered Users and Adds Dr Henry Friedman to Oncology Advisory Board 14120 1MedTrust Online Surpasses 5 000 Registered Users and Adds Dr Henry Friedman to Oncology Advisory Board 14120 2
... scientists, including a team from The University ... (IMB), is a step closer to the next generation of...comprehensive analysis of the human and mouse tran...nd IMB researcher Professor David Hume said transc... the genome by a cell at any given time. , "Esse...
...rnational Rice Research Institute (IRRI) is workin...South East Asian Nations (ASEAN) to develop a seri... in the region. , When implemented, the indicators...e environmental impact of its rice production with...blems or improve on existing practices. It,s the f...
... isn,t really that sluggish after all. So says the...e creature,s behavior in the wild, which was just ...l Bulletin. , The new research is significant bec...dibranch mollusc species found in the shallow nort...of the how the brain controls behavior, a field kn...
Other Biology News:Learning the language of DNA 2A cleaner, greener rice industry 2The secret lives of sea slugs 2
(Date:12/3/2009)SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today anno
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...n collaboration with the Chinese Academy of Scienc...tation of molecules on a fixed surface to understa...rotor-based machinery at nanoscale level. , The...ch play an important part in machines like electri...logy at the atomic scale is to replicate this prop...
...RCROSS, Ga., May 27 Immucor, Inc. (Nasdaq: BLUD...ent-reagent systems to the blood transfusion indus...r agreement with Alverno Clinical Laboratories, LL... integrated delivery systems in the nation, servin...r the agreement, Alverno is standardizing pre-tran...
...rst clinical study evaluating DUROS(R) continuous ...diabetes , , HAYWARD, Calif., May 27 Intarcia Th...linical data from a phase 1b study of ITCA 650 (DU...reatment of type 2 diabetes as a late-breaker at t...ciation in New Orleans, LA (June 5-9, 2009). The s...
Other Biology Technology:Immucor and Alverno Clinical Laboratories Sign Five-Year Automation Agreement 2Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions 2Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions 3
cAMP Competitive immunoassay Assay Kit, HTRF from Cisbio
...in filters allow for the rapid isolation of DNA fr...ice in the spin filter, centrifuge for 3 minutes, ...s no need to melt agarose or use any special buff...ange, primer removal from PCR reactions, and remov...
Human Atherosclerosis Antibody Array I Kit, ChemiArray, 20 cytokines per membrane from CHEMICON
High-Binding EIA 96 Well Strip Plates from Cayman Chemical
Biology Products: